Policy & Regulation

Baxdrostat gets FDA priority review

Read more

Market barriers are obstacle to growth in EU

Read more

A plan to empower the EU single market

Read more

Advancing investment across Europe

Read more

Public Policy - The EU aims to be global hub for life sciences by 2030

Read more

Compassionate Use - Ensuring access to critical medicines

Read more

The EU-US trade deal: Agreement sets single 15% tariff for most goodss

Read more

Regulators explore alternatives to animal studies

Read more

EU medicines regulators agree AI workplan

Read more

Editorial: Stand up for the FDA

Read more